TRPM4 and prostate carcinoma: In LnCAP prostate cancer cells, TRPM4-associated Ca2+ influx stimulates AKT1, which in turn increases the inhibitory Ser9 phosphorylation of GSK3β and the total amount of β-catenin (Sagredo et al., 2018).